Evaluation of gm-csf mouthwash for prevention of chemotherapy-induced mucositis: A randomized, double-blind, dose-ranging study

Cytokine

Volumn 7, Issue 5, 1995, Pages 471-477

  Cartee, Leanne ^a   Petros, William P ^a   Rosner, Gary L ^a   Gilbert, Colleen ^a   Moore, Sarah ^a   Affronti, Mary Lou ^a   Hoke, James A ^a   Hussein, Atif M ^a   Ross, Maureen ^a   Rubin, Peter ^a   Vredenburgh, James J ^a   Peters, William P ^a  

^a NONE   (United States)

Author keywords

Gm CSF; Mouthwash; Mucositis

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CELL ACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG MECHANISM; FEMALE; HEMATOPOIESIS; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; MALE; MOUTH HYGIENE; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DOXORUBICIN; EVALUATION STUDIES; FEMALE; FLUOROURACIL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LOGISTIC MODELS; MALE; METHOTREXATE; MOUTH MUCOSA; MOUTHWASHES; RISK FACTORS;

EID: 0029044205     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1995.0064     Document Type: Article

References (29)

1. Sonis ST, Clark J (1991) Prevention and management of oral mucositis induced by antineoplastic therapy. Oncology 5:11-22.
2. Poland J (1991) Prevention and treatment of oral complications in the cancer patient. Oncology 5:45-50.
3. Sonis ST, Lockhart PB (1984) Oral complications of chemotherapy and their management. In Shklar G (ed) Oral Cancer, W. B. Saunders, Philadelphia, pp 186-201.
4. Sonis ST (1983) Epidemiology, frequency, distribution, mechanisms, and histopathology. In Peterson DE, Sonis ST (eds) Oral Complications of Cancer Chemotherapy, Martinus Nijhoff Publishers, Hague, Germany, pp 1-12.
5. Sonis ST (1989) Oral complications of cancer therapy. In DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: Principles and Practice of Oncology, 3rd ed, JB Lippincott, Philadelphia, pp 2144-2152.
6. Rothwell BR, Spektor WS (1990) Palliation of radiation-related mucositis. Spec Care Dentist 10:21-25.
7. Barker G, Loftus L, Cuddy P, Barker B (1991) The effects of sucralfate suspension and diphenhydramine syrup plus kaolin-pectin on radiotherapy-induced mucositis. Oral Surg Oral Pathol 71:288-293.
8. Clark PI, Selvin ML (1985) Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity. Eur J Surg Oncol 11:267-268.
9. Tsavaris N, Caragiauris P, Kosmidis P (1988) Reduction of oral toxicity of 5-fluorouracil by allopurinol mouthwashes. Eur J Surg Oncol 14:405-406.
10. Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, Sorensen JM, Gainey DK, Mailliard JA, Gusa NL, Finck GK, Johnson C, Goldberg RM (1991) Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 9:449-452.
11. Gasson JC (1991) Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77:1131-1145.
12. Lopez AF, Williamson DJ, Gamble JR, Begley CG, Harlan JM, Klebanoff SJ, Waltersdorf A, Wong G, Clark SC, Vadas MA (1986) Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest 78:1220-1228.
13. Wang M, Friedman H, Djeu JV (1989) Enhancement of human monocyte function against candida albicans by the colony-stimulating factors (csf): IL-3, granulocyte-macrophage-csf, and macrophage-csf. J Immuno 143:671-677.
14. Cannistra SA, Vellenga E, Groshek P, Rambaldi A, Griffin JD (1988) Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism. Blood 71:672-676.
15. Wing EJ, Magee DM, Whiteside TL, Kaplan SS, Shadduck RK (1989) Recombinant human granulocyte/macrophage colony stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor-dependent mechanism. Blood 73:643-646.
16. Heidenreich S, Gong JH, Schmidt A, Nain M, Gemsa D (1989) Macrophage activation by granulocyte/macrophage colony-stimulating factor. J Immunol 143:1198-1205.
17. Reed SG, Nathan CF, Pihl DL, Rodricks P, Shanebeck K, Conlon PJ, Grabstein KH (1987) Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit trypanosoma cruzi and release hydrogen peroxide. J Exp Med 166:1734-1746.
18. Ho AD, Francesco DV, Haas RV, Englehard M, Hiddemann W, Ruckle H, Schlimok G, Thiel E, Andreesen R, Fiedler W, Frisch J, Schulz G, Hustein W (1990) Sequential studies on the role of mitox-anthrone, high-dose cytarabine, and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of refractory nonHodgkin’s lymphoma. Semin Oncol 17(Suppl 10): 14-19.
19. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MAS, Clarkson B, Oettgen HF, Alton K, Welte K, Souza L (1988) Effects of granulocyte-macrophage colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothe-lium. N Eng J Med 318:1414-1422.
20. Kanz L, Lindemann A, Oster W, Herrmann F, Mertelsmann R (1991) Hemopoietins in clinical oncology. Am J Clin Oncol 14(Suppl 1):27-29.
21. Jones RB, Shpall EJ, Shogan J, Affronti ML, Coniglio RPA, Hart L, Halperin E, Iglehart JD, Moore J, Gockerman J, Bast RC, Peters WP (1990) The Duke AFM Program: intensive induction chemotherapy for metastatic breast cancer. Cancer 66:431-436.
22. Lockhart PB, Sonis ST (1979) Relationship of oral complications to peripheral blood leucocyte and platelet counts in patients with acute leukemia. Oral Surg Oral Med Oral Pathol 48:21-27.
23. Wright DG, Meierovics AI, Foxley JM (1986) Assessing the delivery of neutrophils to tissues in neutropenia. Blood 67:1023-1030.
24. Sonis ST, Koplowsky A, Mitus J, Rosenthal D, Brand M (1992) Relationship of chemotherapy induced mucositis and myelo-suppression in hamsters. Eur J Cancer 28: 43.
25. Chow AW (1990) Infections of the oral cavity, neck, and head. In Mandell GL, Douglas RG Jr, Bennett JE (eds) Principles and Practice of Infectious Diseases, 3rd ed, Churchill Livingstone, New York, pp 516-526.
26. Peterson DE, Minah GE, Reynolds MA (1990) Effect of granulocytopenia on oral microbial relationships in patients with acute leukemia. Oral Surg Oral Med Oral Pathol 70:720-723.
27. Cantorna MT, Balish E (1990) Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect Immun 58:1093-1099.
28. Lieschke GJ, Ramenghi U, O’Connor MP, Sheridan W, Szer J, Morstyn G (1992) Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation. Br J Haematol 82:589-595.
29. Lobene RR, Weatherford T, Ross NM, Lamm RA, Menaker L (1986) A modified gingival index for use in clinical trials. Clin Prev Dent 8:3-6.